Ralhan R[Author] - Search Results

Year	Number of Results
1985	1
1986	2
1988	2
1990	1
1994	2
1995	7
1996	2
1997	6
1998	7
1999	3
2000	8
2001	7
2002	4
2003	8
2004	5
2005	6
2006	10
2007	12
2008	8
2009	15
2010	19
2011	9
2012	10
2013	8
2014	3
2015	7
2016	6
2017	3
2018	3
2019	1
2020	1
2021	1
2022	2
2024	0

1

RETRACTED: Straticyte demonstrates prognostic value over oral epithelial dysplasia grade for oral potentially malignant lesion assessment.

Hwang JTK, Gu YR, Dickson BJ, Shen M, Ralhan R, Walfish PG, Mock D, Pritzker KPH. Hwang JTK, et al. Among authors: ralhan r. Oral Oncol. 2017 Sep;72:1-6. doi: 10.1016/j.oraloncology.2017.06.024. Epub 2017 Jun 29. Oral Oncol. 2017. PMID: 28797444

2

Nuclear factor-kappa B links carcinogenic and chemopreventive agents.

Ralhan R, Pandey MK, Aggarwal BB. Ralhan R, et al. Front Biosci (Schol Ed). 2009 Jun 1;1(1):45-60. doi: 10.2741/S6. Front Biosci (Schol Ed). 2009. PMID: 19482682 Free article. Review.

3

14-3-3 zeta as novel molecular target for cancer therapy.

Matta A, Siu KW, Ralhan R. Matta A, et al. Among authors: ralhan r. Expert Opin Ther Targets. 2012 May;16(5):515-23. doi: 10.1517/14728222.2012.668185. Epub 2012 Apr 18. Expert Opin Ther Targets. 2012. PMID: 22512284 Review.

4

Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.

Matta A, Ralhan R, DeSouza LV, Siu KW. Matta A, et al. Among authors: ralhan r. Mass Spectrom Rev. 2010 Nov-Dec;29(6):945-61. doi: 10.1002/mas.20296. Mass Spectrom Rev. 2010. PMID: 20945361 Review.

5

Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review.

Warnakulasuriya KA, Ralhan R. Warnakulasuriya KA, et al. Among authors: ralhan r. J Oral Pathol Med. 2007 Feb;36(2):63-77. doi: 10.1111/j.1600-0714.2007.00496.x. J Oral Pathol Med. 2007. PMID: 17238967 Review.

6

How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?

Ralhan R. Ralhan R. Expert Rev Proteomics. 2012 Apr;9(2):115-8. doi: 10.1586/epr.12.1. Expert Rev Proteomics. 2012. PMID: 22462781 No abstract available.

7

The Hemolyzed Sample: To Analyse Or Not To Analyse.

Bhargava S, Singla P, Manocha A, Kankra M, Sharma A, Ahirwar A, Ralhan R, Thapliyal U, Mehra P. Bhargava S, et al. Among authors: ralhan r. Indian J Clin Biochem. 2020 Apr;35(2):232-238. doi: 10.1007/s12291-019-00821-4. Epub 2019 Mar 11. Indian J Clin Biochem. 2020. PMID: 32226256 Free PMC article.

8

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.

Kunavisarut T, Kak I, Macmillan C, Ralhan R, Walfish PG. Kunavisarut T, et al. Among authors: ralhan r. BMC Cancer. 2012 Nov 15;12:523. doi: 10.1186/1471-2407-12-523. BMC Cancer. 2012. PMID: 23153310 Free PMC article.

9

Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications.

Srivastava A, Ralhan R, Kaur J. Srivastava A, et al. Among authors: ralhan r. Microsc Res Tech. 2003 Feb 1;60(2):208-24. doi: 10.1002/jemt.10259. Microsc Res Tech. 2003. PMID: 12539175 Review.

10

Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model.

Hasan R, Srivastava G, Alyass A, Sharma R, Saraya A, Chattopadhyay TK, DattaGupta S, Walfish PG, Chauhan SS, Ralhan R. Hasan R, et al. Among authors: ralhan r. Oncotarget. 2022 Sep 14;13:1020-1032. doi: 10.18632/oncotarget.10656. eCollection 2022. Oncotarget. 2022. PMID: 36128326 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

172 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year